Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

MyNCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1832 1
1835 1
1841 1
1909 1
1911 3
1913 4
1914 3
1915 4
1916 1
1917 1
1931 1
1932 1
1933 2
1935 1
1938 1
1939 2
1940 2
1944 3
1945 1
1946 1
1947 3
1948 1
1949 5
1950 5
1951 1
1952 3
1953 4
1954 2
1957 3
1958 8
1960 1
1961 1
1962 1
1963 5
1964 3
1965 5
1966 6
1967 9
1968 13
1969 9
1970 16
1971 20
1972 16
1973 18
1974 12
1975 12
1976 16
1977 16
1978 19
1979 17
1980 9
1981 14
1982 11
1983 10
1984 16
1985 11
1986 18
1987 11
1988 15
1989 18
1990 13
1991 19
1992 26
1993 25
1994 29
1995 30
1996 31
1997 29
1998 27
1999 31
2000 39
2001 31
2002 41
2003 46
2004 38
2005 55
2006 66
2007 69
2008 69
2009 81
2010 72
2011 100
2012 88
2013 90
2014 98
2015 78
2016 112
2017 105
2018 106
2019 107
2020 38
Text availability
Article attribute
Article type
Publication date

Search Results

2,034 results
Results by year
Filters applied: . Clear all
Page 1
Exercise management in type 1 diabetes: a consensus statement.
Riddell MC, Gallen IW, Smart CE, Taplin CE, Adolfsson P, Lumb AN, Kowalski A, Rabasa-Lhoret R, McCrimmon RJ, Hume C, Annan F, Fournier PA, Graham C, Bode B, Galassetti P, Jones TW, Millán IS, Heise T, Peters AL, Petz A, Laffel LM. Riddell MC, et al. Among authors: Graham C. Lancet Diabetes Endocrinol. 2017 May;5(5):377-390. doi: 10.1016/S2213-8587(17)30014-1. Epub 2017 Jan 24. Lancet Diabetes Endocrinol. 2017. PMID: 28126459 Review.
The MCL1 inhibitor S63845 is tolerable and effective in diverse cancer models.
Kotschy A, Szlavik Z, Murray J, Davidson J, Maragno AL, Le Toumelin-Braizat G, Chanrion M, Kelly GL, Gong JN, Moujalled DM, Bruno A, Csekei M, Paczal A, Szabo ZB, Sipos S, Radics G, Proszenyak A, Balint B, Ondi L, Blasko G, Robertson A, Surgenor A, Dokurno P, Chen I, Matassova N, Smith J, Pedder C, Graham C, Studeny A, Lysiak-Auvity G, Girard AM, Gravé F, Segal D, Riffkin CD, Pomilio G, Galbraith LC, Aubrey BJ, Brennan MS, Herold MJ, Chang C, Guasconi G, Cauquil N, Melchiore F, Guigal-Stephan N, Lockhart B, Colland F, Hickman JA, Roberts AW, Huang DC, Wei AH, Strasser A, Lessene G, Geneste O. Kotschy A, et al. Among authors: Graham C. Nature. 2016 Oct 27;538(7626):477-482. doi: 10.1038/nature19830. Epub 2016 Oct 19. Nature. 2016. PMID: 27760111
Allogeneic CAR-T Cells: More than Ease of Access?
Graham C, Jozwik A, Pepper A, Benjamin R. Graham C, et al. Cells. 2018 Oct 1;7(10):155. doi: 10.3390/cells7100155. Cells. 2018. PMID: 30275435 Free PMC article. Review.
Progression of whole-blood transcriptional signatures from interferon-induced to neutrophil-associated patterns in severe influenza.
Dunning J, Blankley S, Hoang LT, Cox M, Graham CM, James PL, Bloom CI, Chaussabel D, Banchereau J, Brett SJ, Moffatt MF, O'Garra A, Openshaw PJM; MOSAIC Investigators. Dunning J, et al. Among authors: Graham CM. Nat Immunol. 2018 Jun;19(6):625-635. doi: 10.1038/s41590-018-0111-5. Epub 2018 May 18. Nat Immunol. 2018. PMID: 29777224 Free PMC article.
The Hippo Pathway Component TAZ Promotes Immune Evasion in Human Cancer through PD-L1.
Janse van Rensburg HJ, Azad T, Ling M, Hao Y, Snetsinger B, Khanal P, Minassian LM, Graham CH, Rauh MJ, Yang X. Janse van Rensburg HJ, et al. Among authors: Graham CH. Cancer Res. 2018 Mar 15;78(6):1457-1470. doi: 10.1158/0008-5472.CAN-17-3139. Epub 2018 Jan 16. Cancer Res. 2018. PMID: 29339539 Free article.
Adjunctive rifampicin for Staphylococcus aureus bacteraemia (ARREST): a multicentre, randomised, double-blind, placebo-controlled trial.
Thwaites GE, Scarborough M, Szubert A, Nsutebu E, Tilley R, Greig J, Wyllie SA, Wilson P, Auckland C, Cairns J, Ward D, Lal P, Guleri A, Jenkins N, Sutton J, Wiselka M, Armando GR, Graham C, Chadwick PR, Barlow G, Gordon NC, Young B, Meisner S, McWhinney P, Price DA, Harvey D, Nayar D, Jeyaratnam D, Planche T, Minton J, Hudson F, Hopkins S, Williams J, Török ME, Llewelyn MJ, Edgeworth JD, Walker AS; United Kingdom Clinical Infection Research Group (UKCIRG). Thwaites GE, et al. Among authors: Graham C. Lancet. 2018 Feb 17;391(10121):668-678. doi: 10.1016/S0140-6736(17)32456-X. Epub 2017 Dec 14. Lancet. 2018. PMID: 29249276 Free PMC article. Clinical Trial.
Further developments.
Graham CA. Graham CA. Eur J Emerg Med. 2017 Oct;24(5):317. doi: 10.1097/MEJ.0000000000000497. Eur J Emerg Med. 2017. PMID: 28841591 No abstract available.
A modular transcriptional signature identifies phenotypic heterogeneity of human tuberculosis infection.
Singhania A, Verma R, Graham CM, Lee J, Tran T, Richardson M, Lecine P, Leissner P, Berry MPR, Wilkinson RJ, Kaiser K, Rodrigue M, Woltmann G, Haldar P, O'Garra A. Singhania A, et al. Among authors: Graham CM. Nat Commun. 2018 Jun 19;9(1):2308. doi: 10.1038/s41467-018-04579-w. Nat Commun. 2018. PMID: 29921861 Free PMC article.
Removing the Barriers from the Path to Eliminate Hepatitis C.
Graham CS, Trooskin SB. Graham CS, et al. Infect Dis Clin North Am. 2018 Jun;32(2):xv-xvi. doi: 10.1016/j.idc.2018.03.001. Infect Dis Clin North Am. 2018. PMID: 29778268 No abstract available.
A mechanism of hypoxia-mediated escape from adaptive immunity in cancer cells.
Barsoum IB, Smallwood CA, Siemens DR, Graham CH. Barsoum IB, et al. Among authors: Graham CH. Cancer Res. 2014 Feb 1;74(3):665-74. doi: 10.1158/0008-5472.CAN-13-0992. Epub 2013 Dec 13. Cancer Res. 2014. PMID: 24336068 Free article.
2,034 results
Jump to page
Feedback